Item 8.01. Other Events
On June 2, 2022, InVivo Therapeutics Holdings Corp. (the "Company") issued a
press release announcing that the Company has completed enrollment in its
INSPIRE 2.0 Study for acute spinal cord injury. A copy of this press release is
filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by
reference to this Item 8.01.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press Release, dated June 2, 2022, of InVivo Therapeutics Holdings Corp.
104 Cover Page Interactive Data File (formatted as Inline XBRL).
© Edgar Online, source Glimpses